Skip to main content

Erratum to: In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine

Erratum to: Cancer Cell Int (2016) 16:45 DOI 10.1186/s12935-016-0317-2

Following publication of the original article [1] it was brought to our attention that the second author name had been misspelt. Please note that the second author name should be “Zhang Xiumin” and not “Zhan Xiumin” as was originally presented.

Reference

  1. 1.

    Junwei W, Xiumin Z, Shoujing Y, Zengshan L. In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine. Cancer Cell Int. 2016;16:45. doi:10.1186/s12935-016-0317-2.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Li Zengshan.

Additional information

The online version of the original article can be found under doi:10.1186/s12935-016-0317-2.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Junwei, W., Xiumin, Z., Jing, Y. et al. Erratum to: In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine. Cancer Cell Int 17, 10 (2017). https://doi.org/10.1186/s12935-016-0375-5

Download citation